Taken together, these data indicate higher expression of MET mRNA and c-MET protein in Barrett’s esophagus and esophageal adenocarcinoma compared with NSE and benign conditions (inflammation and hyperplasia). This evidence concerns the gene ENO2 and Barrett esophagus.